TGFB1 and hepatocellular carcinoma: In HBV-positive hepatocellular carcinoma, an increase in TGF-β signaling suppresses the expression of miR-34a, resulting in enhanced production of the chemokine CCL22 and recruitment of Treg cells, promoting the development of intrahepatic venous metastasis [32].